AbbVie CEO Gonzales loses Shire, but wins praise for gusty move

NEW YORK, Oct 20 (Reuters) - AbbVie Chief Executive Officer Richard Gonzalez for three months led the charge to buy Dublin drugmaker Shire for $55 billion, only to walk away from the deal last week, but analysts and fund managers said he deserves credit for trying and should remain at the helm of the Chicago drugmaker.